An open-label study of the role of adjuvant hemostatic support with protein C replacement therapy in purpura fulminans-associated meningococcemia

Blood

Volumn 96, Issue 12, 2000, Pages 3719-3724

  White, Barry ^a   Livingstone, Wendy ^a   Murphy, Ciaran ^a   Hodgson, Andrew ^a   Rafferty, Marie ^a   Smith, Owen P ^a  

^a ST JAMES S HOSPITAL   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATED PROTEIN C; ANTITHROMBIN III; PROTEIN S;

ADOLESCENT; ADULT; AGED; AMPUTATION; ANTICOAGULATION; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG EFFICACY; FEMALE; FULMINATING PURPURA; GLASGOW COMA SCALE; HEMOSTASIS; HUMAN; INFANT; MALE; MENINGOCOCCEMIA; MORTALITY; MULTIPLE ORGAN FAILURE; NEISSERIA MENINGITIDIS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN C DEFICIENCY; SEPTIC SHOCK;

EID: 0034548822     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v96.12.3719     Document Type: Article

References (49)

1. Trends in mortality in children hospitalized with meningococcal infections, 1957 to 1987
2. Adult overwhelming meningococcal purpura: A study of 35 cases, 1977-1989
3. Intravascular coagulation in fulminant meningococcemia
4. Sepsis and intravascular thrombosis
5. Endotoxin induced coagulation activation and protein C reduction in meningococcal septic shock
6. Coagulation activation and tissue necrosis in meningococcal septic shock: Severely reduced protein C levels predict a high mortality
7. Epidemic meningococcemia and purpura fulminans with induced protein C deficiency
8. The roles of protein C and thrombomodulin in the regulation of blood coagulation
9. Identification, cloning, and regulation of a novel endothelial cell protein C/activated protein C receptor
10. Possible involvement of cytokines in diffuse intravascular coagulation and thrombosis
11. Endothelial protein C receptor
12. Protein C prevents the coagulopathic and lethal effects of Escherichia coli infusion in the baboon
13. Activated protein C attenuates endotoxin-induced pulmonary vascular injury by inhibiting activated leukocytes in rats
14. Selective inhibitory effects of the anticoagulant activated protein C on the responses of human mononuclear phagocytes to LPS, IFN-gamma, or phorbol ester
15. Association between tumour necrosis factor in serum and fatal outcome in patients with meningococcal disease
16. Correlation between proinflammatory cytokines and antiinflammatory mediators and the severity of disease in meningococcal infections
17. Differential expression of proinflammatory cytokines and their inhibitors during the course of meningococcal infections
18. Use of protein-C concentrate, heparin, and haemodiafiltration in meningococcus-induced purpura fulminans
19. Protein C in the treatment of coagulopathy in meningococcal disease
20. Treatment of purpura fulminans in meningococcemia with protein C concentrate
21. Prognosis of meningococcal septicaemia
22. Validation of the Glasgow Meningococcal Septicemia Prognostic Score: A 10-year retrospective survey
23. Rapid diagnosis of acute meningococcal infections by needle aspiration or biopsy of skin lesions
24. Pathophysiology, treatment and outcome of meningococcemia: A review and recent experience
25. Extremity amputations in meningococcemia-induced purpura fulminans
26. Memoire sur le maladie qui a regne a Geneve au primtemps de 1805
27. Preliminary evaluation of recombinant amino-terminal fragment of human bactericidal/permeability-increasing protein in children with severe meningococcal sepsis
28. Extracorporeal support for intractable cardiorespiratory failure due to meningococcal disease
29. Changing patterns of case ascertainment and trends in meningococcal disease in England and Wales
30. Hemorrhagic stroke as a complication of bacterial meningitis in adults: Report of three cases and review
31. Coincident meningitis and intracerebral hemorrhage in an unresponsive adult
32. Fulminating meningococcal septicaemia presenting with subarachnoid haemorrhage
33. On a case of subarachnoid hemorrhage in the course of hyperacute meningococcic sepsis
34. Hereditary protein C-deficiency: Laboratory values in transmitters and guidelines for the diagnostic procedure: Report on a study of the SSC Subcommittee on Protein C and Protein S
35. Increased risk of venous thrombosis in carriers of hereditary protein C deficiency defect
36. Septic shock, multiple organ failure, and disseminated intravascular coagulation: Compared patterns of antithrombin III, protein C, and protein S deficiencies
37. Endotoxin enhances tissue factor and suppresses thrombomodulin expression of human vascular endothelium in vitro
38. Molecular mechanisms of thrombosis in meningococcal septicaemia: The role of the protein C pathway in vivo
39. Genetic influence on cytokine production in meningococcal disease
40. The relationship between plasminogen activator inhibitor-1 and proinflammatory and counterinflammatory mediators in children with meningococcal septic shock
41. 4G/5G promoter polymorphism in the plasminogen-activator-inhibitor-1 gene and outcome of meningococcal disease: Meningococcal Research Group
42. Variation in plasminogen-activator-inhibitor-1 gene and risk of meningococcal septic shock
43. Increased tissue thromboplastin activity in monocytes of patients with meningococcal infection: Related to an unfavourable prognosis
44. Infectious purpura fulminans: Diagnosis and treatment
45. Regulation of murine protein C gene expression in vivo: Effects of tumor necrosis factor-alpha, intedeukin-1, and transforming growth factor-beta
46. Activation of protein C and its distribution between its inhibitors, protein C inhbitor, α1-antitrypsin, α2-macroglobulin, in patients with disseminated intravascular coagulation
47. Regulation of murine protein C gene expression in vivo: Effects of tumor necrosis factor-alpha, interleukin-1, and transforming growth factor-beta
48. Serial studies of protein C and its plasma inhibitor in patients with disseminated intravascular coagulation
49. Binding of activated protein C to a specific receptor on human mononuclear phagocytes inhibits intracellular calcium signaling and monocyte-dependent proliferative responses